169 related articles for article (PubMed ID: 37895925)
1. Is a 4 J/cm
Fronville M; Creusot M; Mordon SR
Pharmaceuticals (Basel); 2023 Oct; 16(10):. PubMed ID: 37895925
[No Abstract] [Full Text] [Related]
2. Clinical evaluation of a short illumination duration (1 hour) when performing photodynamic therapy of actinic keratosis using the Dermaris light source.
Creusot M; Mordon S
Photodiagnosis Photodyn Ther; 2021 Dec; 36():102618. PubMed ID: 34743007
[TBL] [Abstract][Full Text] [Related]
3. No room for pain: A prospective study showing effective and nearly pain-free treatment of actinic keratosis with simulated daylight photodynamic therapy (SDL-PDT) using the IndoorLux® System in combination with BF-200 ALA (Ameluz®).
Bai-Habelski JC; Medrano K; Palacio A; Reinhold U
Photodiagnosis Photodyn Ther; 2022 Mar; 37():102692. PubMed ID: 34923153
[TBL] [Abstract][Full Text] [Related]
4. Effective fluence and dose at skin depth of daylight and lamp sources for PpIX-based photodynamic therapy.
Ruiz AJ; LaRochelle EPM; Samkoe KS; Chapman MS; Pogue BW
Photodiagnosis Photodyn Ther; 2023 Mar; 41():103260. PubMed ID: 36627070
[TBL] [Abstract][Full Text] [Related]
5. How Much Protoporphyrin IX Must Be Activated to Obtain Full Efficacy of Methyl Aminolevulinate Photodynamic Therapy? Implication for Treatment Modifications.
Wulf HC; Heerfordt IM; Philipsen PA
Pharmaceuticals (Basel); 2021 Apr; 14(4):. PubMed ID: 33917339
[TBL] [Abstract][Full Text] [Related]
6. Comparison of 10 efficient protocols for photodynamic therapy of actinic keratosis: How relevant are effective light dose and local damage in predicting the complete response rate at 3 months?
Vignion-Dewalle AS; Baert G; Thecua E; Lecomte F; Vicentini C; Abi-Rached H; Mortier L; Mordon S
Lasers Surg Med; 2018 Jul; 50(5):576-589. PubMed ID: 29667728
[TBL] [Abstract][Full Text] [Related]
7. Artificial White Light vs Daylight Photodynamic Therapy for Actinic Keratoses: A Randomized Clinical Trial.
O'Gorman SM; Clowry J; Manley M; McCavana J; Gray L; Kavanagh A; Lally A; Collins P
JAMA Dermatol; 2016 Jun; 152(6):638-44. PubMed ID: 26843523
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy for actinic keratosis of the forehead and scalp with the Aktilite CL 128: Is there a cut-off value for PpIX-weighted irradiance for effective treatment?
Vicentini C; Vignion-Dewalle AS; Thecua E; Lecomte F; Béhal H; Maire C; Tylcz JB; Abi-Rached H; Mortier L; Mordon S
Photodermatol Photoimmunol Photomed; 2019 Jul; 35(4):232-237. PubMed ID: 30762242
[TBL] [Abstract][Full Text] [Related]
9. The conventional protocol vs. a protocol including illumination with a fabric-based biophotonic device (the Phosistos protocol) in photodynamic therapy for actinic keratosis: a randomized, controlled, noninferiority clinical study.
Mordon S; Vignion-Dewalle AS; Abi-Rached H; Thecua E; Lecomte F; Vicentini C; Deleporte P; Béhal H; Kerob D; Hommel T; Duhamel A; Szeimies RM; Mortier L
Br J Dermatol; 2020 Jan; 182(1):76-84. PubMed ID: 31021404
[TBL] [Abstract][Full Text] [Related]
10. Weather conditions and daylight-mediated photodynamic therapy: protoporphyrin IX-weighted daylight doses measured in six geographical locations.
Wiegell SR; Fabricius S; Heydenreich J; Enk CD; Rosso S; Bäumler W; Baldursson BT; Wulf HC
Br J Dermatol; 2013 Jan; 168(1):186-91. PubMed ID: 22860885
[TBL] [Abstract][Full Text] [Related]
11. Quantifying the radiant exposure and effective dose in patients treated for actinic keratoses with topical photodynamic therapy using daylight and LED white light.
Manley M; Collins P; Gray L; O'Gorman S; McCavana J
Phys Med Biol; 2018 Jan; 63(3):035013. PubMed ID: 29192611
[TBL] [Abstract][Full Text] [Related]
12. Continuous activation of PpIX by daylight is as effective as and less painful than conventional photodynamic therapy for actinic keratoses; a randomized, controlled, single-blinded study.
Wiegell SR; Haedersdal M; Philipsen PA; Eriksen P; Enk CD; Wulf HC
Br J Dermatol; 2008 Apr; 158(4):740-6. PubMed ID: 18294318
[TBL] [Abstract][Full Text] [Related]
13. Pre-treatment protoporphyrin IX concentration in actinic keratosis lesions may be a predictive biomarker of response to aminolevulinic-acid based photodynamic therapy.
Kanick SC; Davis SC; Zhao Y; Sheehan KL; Hasan T; Maytin EV; Pogue BW; Chapman MS
Photodiagnosis Photodyn Ther; 2015 Dec; 12(4):561-6. PubMed ID: 26480810
[TBL] [Abstract][Full Text] [Related]
14. Continuous ultra-low-intensity artificial daylight is not as effective as red LED light in photodynamic therapy of multiple actinic keratoses.
Wiegell SR; Heydenreich J; Fabricius S; Wulf HC
Photodermatol Photoimmunol Photomed; 2011 Dec; 27(6):280-5. PubMed ID: 22092730
[TBL] [Abstract][Full Text] [Related]
15. Split-face study comparing conventional MAL photodynamic therapy in multiple actinic keratosis with complete time vs. half-time red light LED conventional illumination.
Fernández-Guarino M; Fonda Pascual P; Lizuain Gomez P; Harto Castaño A; Jaén Olasolo P
J Eur Acad Dermatol Venereol; 2019 Aug; 33(8):1529-1534. PubMed ID: 30868672
[TBL] [Abstract][Full Text] [Related]
16. Ultraviolet radiation exposure during daylight Photodynamic Therapy.
McLellan LJ; O'Mahoney P; Khazova M; Higlett M; Ibbotson SH; Eadie E
Photodiagnosis Photodyn Ther; 2019 Sep; 27():19-23. PubMed ID: 31117000
[TBL] [Abstract][Full Text] [Related]
17. Bringing the gentle properties of daylight photodynamic therapy indoors: A systematic review of efficacy and safety.
Heerfordt IM; Philipsen PA; Wulf HC
Photodiagnosis Photodyn Ther; 2022 Sep; 39():102858. PubMed ID: 35421601
[TBL] [Abstract][Full Text] [Related]
18. Daylight photodynamic therapy for severe facial and scalp actinic keratosis: a prospective non-sponsored single-centre study employing the actinic keratosis area and severity index (AKASI).
Jordan M; Ghoreschi K; Eberle FC
Eur J Dermatol; 2019 Feb; 29(1):67-74. PubMed ID: 30827943
[TBL] [Abstract][Full Text] [Related]
19. Combined daylight and conventional photodynamic therapy with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis of the face and scalp: a new and efficient approach.
Salido-Vallejo R; Jiménez-Nájar F; Garnacho-Sucedo G; Vélez A
Arch Dermatol Res; 2020 Nov; 312(9):675-680. PubMed ID: 31838569
[TBL] [Abstract][Full Text] [Related]
20. Can daylight-PDT be performed indoor?
Mordon S; Vignion-Dewalle AS; Thecua E; Vicentini C; Maire C; Deleporte P; Baert G; Lecomte F; Mortier L
G Ital Dermatol Venereol; 2018 Dec; 153(6):811-816. PubMed ID: 29417802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
